Hunan Norchem Pharmaceutical Co.

BiotechnologySeries BChangde, Chinanorchem-pharma.com

Latest round

Series B

Last raised

Dec 2023

Total raised

Undisclosed

Investors

9

About Hunan Norchem Pharmaceutical Co.

,Ltd. operates as a pharmaceutical research and development manufacturer, focusing on steroid drug intermediates and APIs. The company also established more than 10 branch subsidiaries in Hunan, Beijing, Guangdong, and other places. It has also established two intermediate factories, a sex hormone API factory, and a formulation factory. Norchem has applied for 27 invention patents, 17 of which have been granted. Norchem is dedicated to the production of various pharmaceutical APIs and intermediates using biological fermentation and chemical synthesis with phytosterols as the starting material. The products of the company can be categorized into five categories which are betamethasone series, dexamethasone series, hydrocortisone series, prednisolone series, and progestin intermediates. Products within include betamethasone epoxide hydrolysate, dexamethasone epoxide hydrolysate acetate, hydrocortisone intermediate ester, prednisolone acetate, and acid decarboxylate.

Who invested in Hunan Norchem Pharmaceutical Co.

9 investors across 1 round

See all investors in Hunan Norchem Pharmaceutical Co.

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series B

    Dec 15, 2023

    Amount

    Undisclosed

    Investors

    Locked

Questions about Hunan Norchem Pharmaceutical Co.

Who invested in Hunan Norchem Pharmaceutical Co.?

Hunan Norchem Pharmaceutical Co. has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has Hunan Norchem Pharmaceutical Co. raised?

Hunan Norchem Pharmaceutical Co. has raised 1 venture round. Sign up free to see how much each round raised and the total.

When did Hunan Norchem Pharmaceutical Co. last raise money?

Hunan Norchem Pharmaceutical Co.'s most recent round on record is a Series B, in Dec 2023.

What does Hunan Norchem Pharmaceutical Co. do?

Hunan Norchem Pharmaceutical Co. is a biotechnology company.

Where is Hunan Norchem Pharmaceutical Co. headquartered?

Hunan Norchem Pharmaceutical Co. is headquartered in Changde, China.

Which VCs invest in companies like Hunan Norchem Pharmaceutical Co.?

Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Hunan Norchem Pharmaceutical Co.'s stage. Their profiles are linked below.

Raising like Hunan Norchem Pharmaceutical Co.? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.